他汀与风湿病患者较低死亡率:不死时间偏倚效应?
该研究检索PubMed中他汀对常见风湿病(类风湿关节炎、骨关节炎、狼疮、强直性脊柱炎、痛风及系统性自身免疫病)患者全因死亡率影响的观察性研究,纳入8项。其中4项存在经典不死时间偏倚,报告他汀使死亡率降低13%至57%;另4项通过随机日历日期分配引入不死时间于对照组,报告死亡率降低16%至37%。结论认为观察性研究中的偏倚可能解释其与随机对照试验结果的不一致。
要点
- 观察性研究报告他汀显著降低风湿病患者死亡率,但随机对照试验显示有限或无获益。
- 8项观察性研究中4项存在经典不死时间偏倚,另4项因随机日历日期分配引入不死时间于对照组。
- 经典偏倚研究报告死亡率降低13%至57%,随机日历日期分配研究报告降低16%至37%。
核心结论
- 观察性研究中的偏倚可能解释其与随机对照试验关于他汀在风湿病患者中有效性结果的不一致。
- 未来观察性研究需采用模拟随机试验的 incident 和 prevalent new-user 设计以避免不死时间偏倚。
研究设计与样本
- 检索PubMed中调查他汀对常见风湿病患者影响的观察性研究,纳入报告他汀使用者与非使用者全因死亡率估计值的研究。
- 共纳入8项观察性研究,评估每项研究是否存在不死时间偏倚并估计该偏倚对已发表结果的影响。
主要发现
- 4项研究存在经典不死时间偏倚,该偏倚倾向于夸大药物有效性,报告他汀使死亡率降低13%至57%。
- 另4项研究通过随机日历日期分配将不死时间引入对照组,该偏倚倾向于低估有效性,报告死亡率降低16%至37%。
临床怎么用
- 解读观察性研究显示的他汀在风湿病患者中的生存获益时,需警惕不死时间偏倚可能夸大效果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Randomized controlled trials of the effectiveness of statins on rheumatic disease outcomes have shown limited or no benefit. On the other hand, observational studies have reported remarkable effectiveness of statins at reducing mortality in patients with rheumatic diseases. We evaluated these observational studies for the presence of immortal time bias, which tends to exaggerate the effectiveness of drugs by creating a survival advantage for exposed patients. METHODS: We searched PubMed for observational studies investigating the impact of statins in patients with common rheumatic diseases, including rheumatoid arthritis, osteoarthritis, lupus, ankylosing spondylitis, gout and systemic autoimmune diseases. Studies were included if estimates for all-cause mortality among statin users compared to non-users were reported. We evaluated each study for the presence of immortal time bias and estimated the impact of the bias on the published results. RESULTS: We found eight observational studies investigating the impact of statins on mortality among patients with rheumatic diseases. Four studies were affected by the classical variant of immortal time bias, while the others introduced immortal time into the comparator via random-calendar date assignment. The studies with the classical form of immortal time bias, which tends to exaggerate drug effectiveness, reported protective effects of statins on mortality ranging from 13% to 57% reductions. In contrast, immortal time bias through random-calendar date assignment, which tends to play down the effectiveness by introducing immortal time in the comparator, reported 16% to 37% reductions in mortality. CONCLUSION: Bias in observational studies may explain the discrepancy in findings with randomized controlled trials on the effectiveness of statins in patients with rheumatic diseases. Future observational studies will need to rely on incident and prevalent new-user designs that emulate randomized trials and avoid immortal time bias.
引用
- Abrahami D, Hudson M, Suissa S, et al. Statins and lower mortality in rheumatic diseases: An effect of immortal time bias? Semin Arthritis Rheum. 2020. PMID: 33385861. doi:10.1016/j.semarthrit.2020.11.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。